EDGAR Filing Documents for 0001047469-19-005552

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001047469-19-005552

Filing Date

2019-10-02

Accepted

2019-10-02 08:29:14

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	a2239789zs-3.htm	S-3	283357
2	EX-4.4	a2239789zex-4_4.htm	EX-4.4	561228
3	EX-4.6	a2239789zex-4_6.htm	EX-4.6	154832
4	EX-4.7	a2239789zex-4_7.htm	EX-4.7	160052
5	EX-4.8	a2239789zex-4_8.htm	EX-4.8	145454
6	EX-5.1	a2239789zex-5_1.htm	EX-5.1	34428
7	EX-23.1	a2239789zex-23_1.htm	EX-23.1	4006
8	G191642KQI001.GIF	g191642kqi001.gif	GRAPHIC	466
9	G191642KQI002.GIF	g191642kqi002.gif	GRAPHIC	1035
10	G518949.JPG	g518949.jpg	GRAPHIC	21898
11	G519712.JPG	g519712.jpg	GRAPHIC	85350
	Complete submission text file	0001047469-19-005552.txt		1494770

Mailing Address 35 GATEHOUSE DRIVE WALTHAM MA 02451

Business Address 35 GATEHOUSE DRIVE WALTHAM MA 02451 (781) 810-0120

Entasis Therapeutics Holdings Inc. (Filer) CIK: 0001724344 (see all company filings)

IRS No.: 824592913 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-234041 | Film No.: 191130845
SIC: 2834 Pharmaceutical Preparations